CYTK News

Form 8-K

Cytokinetics to Participate in June Investor Conferences

Cytokinetics to Hold Annual Meeting of Stockholders

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)

Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

Identifix’s Direct-Hit® Mobile Brings OEM Repair Manuals to the Bay, Transforms How Repairs Get Done

Form 8-K

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million